Related Experiment Video
Updated: Aug 2, 2025

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
A nuclear NKRF interacting long noncoding RNA controls EBV eradication and suppresses tumor progression in natural
Wen-Fang Wang1, Hui-Juan Zhong2, Shu Cheng2
1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Abstract:
Long intergenic noncoding RNAs (lincRNAs) are differentially expressed in EBV-infected cells and play an essential role in tumor progression. Molecular pathogenesis of lincRNAs in EBV-driven natural killer T cell lymphoma (NKTCL) remains unclear. Here we investigated the ncRNA profile using high-throughput RNA sequencing data of 439 lymphoma samples and screened out LINC00486, whose downregulation was further validated by quantitative real-time polymerase chain reaction in EBV-encoded RNA (EBER)-positive lymphoma, particularly NKTCL. Both in vitro and in vivo studies revealed the tumor suppressive function of LINC00486 through inhibiting tumor cell growth and inducing G0/G1 cell cycle arrest. As mechanism of action, LINC00486 specifically interacted with NKRF to abrogate its binding with phosphorylated p65, activated NF-κB/TNF-α signaling and subsequently enhanced EBV eradication. Solute carrier family 1 member 1 (SLC1A1), upregulated and mediated the glutamine-addiction and tumor progression in NKTCL, was negatively correlated with the expression of NKRF. NKRF specifically bound to the promoter and transcriptionally downregulated the expression of SLC1A1, as evidenced by Chromatin Immunoprecipitation (ChIP) and luciferase assay. Collectively, LINC00486 functioned as a tumor suppressor and counteracted EBV infection in NKTCL. Our study improved the knowledge of EBV-driven oncogenesis in NKTCL and provided the clinical rationale of EBV eradication in anti-cancer treatment.
Insights
Long intergenic noncoding RNA (lincRNA) LINC00486 suppresses Epstein-Barr virus (EBV)-driven natural killer T cell lymphoma (NKTCL) by inhibiting tumor growth and enhancing viral eradication. This lincRNA targets NKRF to modulate NF-κB signaling and SLC1A1 expression.
Area of Science:
- Oncology
- Molecular Biology
- Virology
Background:
- Long intergenic noncoding RNAs (lincRNAs) are implicated in tumor progression, but their role in Epstein-Barr virus (EBV)-driven natural killer T cell lymphoma (NKTCL) is not fully understood.
- Understanding the molecular pathogenesis of lincRNAs in EBV-driven NKTCL is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of lincRNAs in EBV-driven NKTCL.
- To identify specific lincRNAs involved in NKTCL pathogenesis and elucidate their mechanisms of action.
Main Methods:
- High-throughput RNA sequencing of 439 lymphoma samples to profile ncRNA expression.
- Quantitative real-time polymerase chain reaction (qRT-PCR) for validation of LINC00486 downregulation.
- In vitro and in vivo studies to assess the functional role of LINC00486.
- Chromatin Immunoprecipitation (ChIP) and luciferase assays to determine molecular interactions and transcriptional regulation.
Main Results:
- LINC00486 was identified as a significantly downregulated lincRNA in EBV-encoded RNA (EBER)-positive lymphoma, particularly NKTCL.
- LINC00486 demonstrated tumor suppressive functions by inhibiting cell growth and inducing G0/G1 cell cycle arrest.
- LINC00486 interacted with NKRF, abrogating its binding to p65, activating NF-κB/TNF-α signaling, and enhancing EBV eradication.
- NKRF was found to transcriptionally downregulate Solute carrier family 1 member 1 (SLC1A1), a mediator of glutamine addiction and tumor progression in NKTCL.
Conclusions:
- LINC00486 acts as a tumor suppressor in NKTCL by counteracting EBV infection.
- The findings enhance the understanding of EBV-driven oncogenesis in NKTCL.
- Targeting EBV eradication presents a potential clinical strategy for anti-cancer treatment in NKTCL.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Regulation of Nuclear Protein Sorting
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Non-LTR Retrotransposons

